Sr-substituted bone cements direct mesenchymal stem cells, osteoblasts and osteoclasts fate.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28196118.
- Also identified by DOI 10.1371/journal.pone.0172100 and PMC identifier 5308610.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Strontium-substituted apatitic bone cements enriched with sodium alginate were developed as a potential modulator of bone cells fate. The biological impact of the bone cement were investigated in vitro through the study of the effect of the nanostructured apatitic composition and the doping of strontium on mesenchymal stem cells, pre-osteoblasts and osteoclasts behaviours. Up to 14 days of culture the bone cells viability, proliferation, morphology and gene expression profiles were evaluated. The results showed that different concentrations of strontium were able to evoke a cell-specific response, in fact an inductive effect on mesenchymal stem cells differentiation and pre-osteoblasts proliferation and an inhibitory effect on osteoclasts activity were observed. Moreover, the apatitic structure of the cements provided a biomimetic environment suitable for bone cells growth. Therefore, the combination of biological features of this bone cement makes it as promising biomaterials for tissue regeneration.
Medical subject headings
- Bone Cements
- Cell Proliferation
- Mesenchymal Stem Cells
- Osteoblasts
- Osteoclasts
- Strontium